CYP cynata therapeutics limited

News: CYP Cynata Therapeutics Gets EU Regulatory & Ethics Approval For Phase 2 Trial In Graft...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    March 20 (Reuters) - Cynata Therapeutics Ltd (CYP) :

    • EU REGULATORY & ETHICS APPROVAL FOR PHASE 2 TRIAL OF CYP-001 IN GRAFT VERSUS HOST DISEASE

    (([email protected];))

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
19.0¢
Change
-0.005(2.56%)
Mkt cap ! $45.11M
Open High Low Value Volume
19.5¢ 19.5¢ 19.0¢ $9.936K 52.29K

Buyers (Bids)

No. Vol. Price($)
1 26092 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 4741 2
View Market Depth
Last trade - 15.01pm 12/09/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.